Xiangdong. Lu, et.al., Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice., The Journal of biological chemistry, 2008, 283

http://rdf.ncbi.nlm.nih.gov/pubmed/18353770

Xiangdong. Lu, et.al., Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice., The Journal of biological chemistry, 2008, 283

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Mta2<tm1Yzha>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3798814
• Mta2<tm1.1Yzha>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3798815

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• hyperkeratosis_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0001242I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• glomerulonephritis_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0002743I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• skin lesions_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0001212I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• acanthosis_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0001874I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• skin inflammation_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0004947I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased circulating interleukin-2 level_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0008599I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• embryonic lethality, incomplete penetrance_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0011102I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• abnormal craniofacial morphology_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0000428I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• decreased hair follicle number_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0000379I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased T cell proliferation_Mta2<tm1Yzha>/Mta2<tm1Yzha>,Tg(Lck-cre)#Zhu/0
  http://metadb.riken.jp/0005348I129S4SvJaeC57BL6SJLMta2tm1YzhaMta2tm1YzhaTgLckcreZhu0Mta2tm1YzhaTgLckcreZhu
• mesangial cell hyperplasia_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0011427I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased autoantibody level_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0003725I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased kidney cell proliferation_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0011440I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased anti-double stranded DNA antibody level_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0004762I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• decreased body size_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0001265I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased circulating interleukin-4 level_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0008602I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased urine protein level_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0002962I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• panniculitis_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0011164I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• female infertility_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0001926I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• abnormal axial skeleton morphology_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0002114I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• decreased survivor rate_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0008770I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• premature death_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0002083I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• liver inflammation_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0001860I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased T cell proliferation_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0005348I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• dermatitis_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0001194I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased circulating interferon-gamma level_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0008577I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• perinatal lethality, incomplete penetrance_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0011090I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased susceptibility to systemic lupus erythematosus_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0004801I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha
• increased circulating alanine transaminase level_Mta2<tm1.1Yzha>/Mta2<tm1.1Yzha>
  http://metadb.riken.jp/0002941I129S4SvJaeC57BL6FVBNMta2tm11YzhaMta2tm11YzhaMta2tm11Yzha

class

http://purl.org/net/cito/citesAsAuthority

• Mta2<tm1Yzha>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3798814
• Mta2<tm1.1Yzha>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3798815

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD06016
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD06016